Cellebrite DI Ltd. announces the general availability of its “Genesis” platform, positioning it as a new tool for digital investigations. In press materials dated June 11, 2026, the company says Genesis reduces investigation workload and timelines, shifting effort from “weeks” to “minutes.” Cellebrite frames the change as an acceleration of investigative processes, describing Genesis as enabling “unprecedented” speed compared with prior workflows. The announcements are issued from locations including Tysons Corner, Virginia, and Petah Tikva, Israel, and reference the company’s Nasdaq listing (CLBT). Across the releases, the central message is that Genesis is now available to all customers rather than being limited to earlier phases. The company emphasizes efficiency gains—particularly reduced time and improved throughput for investigations—without detailing specific performance benchmarks, customer case studies, or technical specifications in the provided excerpts.